Efficacy of once‐daily glucagon‐like peptide‐1 receptor agonist lixisenatide as an add‐on treatment to basal insulin in Asian and white adults with type 2 diabetes mellitus: An individual‐level pooled analysis of phase III studies
Author:
Affiliation:
1. Department of Endocrinology Qilu Hospital of Shandong University Jinan China
2. BDM Consulting, Inc. Somerset New Jersey USA
3. Sanofi Investment Co., Ltd. Shanghai China
Funder
Sanofi K.K.
Publisher
Wiley
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13504
Reference32 articles.
1. International Diabetes Federation – Facts & figures [Internet]. Available from:https://www.idf.org/aboutdiabetes/what‐is‐diabetes/facts‐figures.html. Accessed November 15 2019.
2. Diabetes in Asia
3. Glucose Tolerance, Insulin Secretion, and Insulin Sensitivity in Nonobese and Obese Japanese Subjects
4. Comparison of postprandial glycaemia in Asians and Caucasians
5. InzucchiSE BergenstalRM BuseJB DiamantM FerranniniE NauckM PetersAL TsapasA WenderR MatthewsDR.Management of hyperglycemia in type 2 diabetes: a patient‐centered approach | diabetes care [Internet]. Available from:https://care.diabetesjournals.org/content/35/6/1364. Accessed November 15 2019.
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of powder of ginsengporia and atractylodis macrocephalae combined with aerobic exercise in the treatment of obese T2DM: A randomized controlled clinical trial;Electronic Journal of Biotechnology;2024-09
2. Biological Markers of Insulin Sensitivity Links with Dietary Antioxidant;Biomarkers in Diabetes;2022-09-30
3. Biological Markers of Insulin Sensitivity Links with Dietary Antioxidant;Biomarkers in Diabetes;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3